Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: The Endurance 1 Trial [Phase 4]

View source ↗

Summary

The Endurance 1 Trial, a Phase 4 study for diabetic macular edema, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northern California Retina Vitreous Associates | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED